Table 1. .
Publication | Location | Age/Sex | Sites Involved | Risk Factor(s) | Treatment Regimen | Outcome |
---|---|---|---|---|---|---|
Campos-Macias et al. (2006) [13] | Japan | 74/M | Skin (multiple sites) Lymph nodes Joints – arthritis, ankylosis, bursitis |
None identified | Itraconazole 400 mg/d × 4 mo, then stopped prematurely Itraconazole 400 mg/d restarted, but taken incorrectly (200 mg/d) |
Final outcome not provided |
Yap (2011) [14] | Malaysia | 70/F | Skin (multiple sites) Systemic – fevers, night sweats, wt loss |
Gardening Pet cats |
Amphotericin 0.7 mg/kg/d for 2 wk, followed by itraconazole 400 mg/d for 8 mo | Resolution |
Ribeiro et al. (2015) [15] | Brazil | 5/M | Skin (multiple sites) Joints – polyarthritis |
None identified | Amphotericin (dose unknown) for 2 wk, followed by itraconazole (dose unknown) for 45 d | Resolution |
Hassan et al. (2016) [6] | USA | 56/M | Skin Joints – bilateral arthritis, bursitis Lungs – pleural effusions Eyes Systemic – fevers, wt loss |
Farmer Alcohol use Type 2 DM |
Liposomal amphotericin 3 mg/kg/d for 1 mo; discharged on itraconazole | Patient lost to follow-up |
Hessler et al. (2017) [16] | California, USA | CNS – chronic meningitis Lungs Systemic – fevers No skin lesions or joint involvement |
Construction worker | Itraconazole for 12 mo | Resolution |
Abbreviations: CNS, central nervous system; DM, diabetes mellitus.